Skip to main content
Start triage

Start triage first, then route to emergency care.

Need urgent help? Start triage first, then route to emergency care.

Roxee Medication Guide

Fenbendazole

Medication reference facts with explicit FDA-approval, off-label, source-limited, and safety context. Roxee does not sell, prescribe, or dispense medications.

Both Reference complete FDA data linked Rx required Paste Multiple FDA labelers Official label facts Owner quick guide first

Veterinary professional?

Showing simplified owner view. Switch to Vet View for full technical detail.

Data freshness

Reference facts
Reference refreshed
Aug 6, 2026, 7:47 p.m.

These are the reference facts Roxee uses on browse cards and quick facts.

FDA applications
FDA application data refreshed
Aug 6, 2026, 7:47 p.m.

Sponsor, product, and application records imported from Animal Drugs @ FDA.

Safety reports
Safety data refreshed
Aug 6, 2026, 7:49 p.m.

openFDA reaction terms and case summaries are supporting evidence, not proof of causality.

Source timing details
Source timing details
  • Reference facts: Source Roxee | Refreshed Aug 6, 2026, 7:47 PM UTC
    The reference fact projection used for browse cards and quick facts.
  • Animal Drugs @ FDA: Source FDA | Refreshed Aug 6, 2026, 7:47 PM UTC
    Applications/products are imported from FDA export data.
  • Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
    Label highlights/doc links are fetched from FDA preview endpoints.
  • openFDA reaction terms: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
Illustration placeholder
Fenbendazole

Fenbendazole

Drug type: Generic ingredient • Generic profile No FDA branded products linked

Both Paste Rx required 100% reference complete

Species: Both

Manufacturer: Multiple FDA labelers

Medication Snapshot

Merged from the current Roxee medication system with field-level provenance, freshness, and completeness tracking.

Fenbendazole

For the treatment and control of large strongyles ( Strongylus edentatus, S. equinus, S. vulgaris, Triodontophorus spp.),small strongyles ( Cyathostomum spp., Cylicocyclus spp., Cylicostephanus spp., Cylicodontophorus spp.), and pinworms ( Oxyuris equi ). For the treatment and control of ascarids ( Parascaris equorum ). For the control of infections of large strongyles (Strongylus edentatus, S. equinus, S. vulgaris), small strongyles, pinworms (Oxyuris equi), and ascarids (Parascaris equorum). Species commonly shown: Both, Horse, Not For Meat Production, Horse, Foals, Not For Food.

Generic name
Fenbendazole
Brand names
safe-guard® panacur®, Panacur® C (OTC) Safe-Guard® Canine (OTC) Panacur® Granules 22.2% (Rx), Safe-Guard®, Safe-Guard® Safe-Guard® EnProAl®
Manufacturer
Multiple FDA labelers
Species
Both, Horse, Pony, Dog
Dosage forms
Paste, Top Dressing In Feed, Liquid (Suspension), Type A Medicated Article
Prescription
Prescription required
Completeness
100%
Validation
Needs review
Brand names
safe-guard® panacur® Panacur® C (OTC) Safe-Guard® Canine (OTC) Panacur® Granules 22.2% (Rx) Safe-Guard® Safe-Guard® Safe-Guard® EnProAl® Safe-Guard® AquaSol Defendazole™
Dosage forms
Paste Top Dressing In Feed Liquid (Suspension) Type A Medicated Article Medicated Feed Block Oral Suspension

Indications / Uses

For the treatment and control of large strongyles ( Strongylus edentatus , S. equinus , S. vulgaris , Triodontophorus spp.),small strongyles ( Cyathostomum spp., Cylicocyclus spp., Cylicostephanus spp., Cylicodontophorus spp.), and pinworms ( Oxyuris equi ). For the treatment and control of ascarids ( Parascaris equorum ). For the control of infections of large strongyles (Strongylus edentatus, S. equinus, S. vulgaris), small strongyles, pinworms (Oxyuris equi), and ascarids (Parascaris equorum).

Warnings / Contraindications

Sprinkle the appropriate amount of drug on a small amount of the usual grain ration. Prepare for each horse individually. Withholding feed or water is not necessary. Retreat in 6 to 8 weeks if required. Do not use in horses intended for food. Consult your veterinarian assistance in the diagnosis, treatment, and control of parasitism. Do not use in horses intended for human consumption. Consult your veterinarian for assistance in the diagnosis, treatment and control of parasitism. Mix the appropriate amount of drug with a small amount of the usual food. Dry dog food may require slight moistening to facilitate mixing. Medicated food must be fully consumed.

  • Sprinkle the appropriate amount of drug on a small amount of the usual grain ration. Prepare for each horse individually. Withholding feed or water is not necessary. Retreat in 6 to 8 weeks if required. Do not use in horses intended for food. Consult your veterinarian assistance in the diagnosis, treatment, and control of parasitism. Do not use in horses intended for human consumption. Consult your veterinarian for assistance in the diagnosis, treatment and control of parasitism. Mix the appropriate amount of drug with a small amount of the usual food. Dry dog food may require slight moistening to facilitate mixing. Medicated food must be fully consumed.

Side Effects

Top reported reactions (openFDA): Lack of efficacy (endoparasite) - hookworm, Vomiting, INEFFECTIVE, HOOKS, Diarrhoea, Other abnormal test result NOS, Lack of efficacy (endoparasite) - tapeworm.

FAQ

Both, Horse, Not For Meat Production, Horse, Foals, Not For Food, Pony, Not For Food, Dog, Non-Lactating, Beef, Dairy, Gilts, Growing, Pregnant sows, Boars, Beef And Dairy, Zoo Animals, Swine, Feral, Wild Animals, Swine, Except For Nursing Piglets, Breeders, Broilers, Layers, Replacements

Yes. Roxee shows this as prescription-only.

Paste, Top Dressing In Feed, Liquid (Suspension), Type A Medicated Article

Related Conditions

Source Transparency

Add to My Pet's Medications

Choose a pet, confirm current or past, and optionally add reminder notes.

Sign in to save this medication to your pet profile.

Sign in to continue

Pet Owner Quick Guide

Start here first for the safest next-step summary before the deeper medication detail.

Used for:

For the treatment and control of: Lungworms: Adult Dictyocaulus viviparus ; Stomach worms: Adult brown stomach worms ( Ostertagia ostertagi ), Adult and fourth stage larvae barberpole worms ( Haemonchus contortus ), four...

Dosing note:

Exact dosing depends on your pet's species, weight, and health status. Use your veterinarian's instructions for the exact dose and schedule.

What to watch for:

  • Sprinkle the appropriate amount of drug on a small amount of the usual grain ration
  • Prepare for each horse individually
  • Withholding feed or water is not necessary
  • Retreat in 6 to 8 weeks if required
  • Do not use in horses intended for food
  • Consult your veterinarian assistance in the diagnosis, treatment, and control of parasitism
  • Do not use in horses intended for human consumption
  • Consult your veterinarian for assistance in the diagnosis, treatment and control of parasitism
  • Mix the appropriate amount of drug with a small amount of the usual food
  • Dry dog food may require slight moistening to facilitate mixing
  • Medicated food must be fully consumed
  • wobbly/unsteady walking (1 reports)
  • Distension of abdomen (1 reports)
  • Digestive tract neoplasm NOS (1 reports)

When to call the vet:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.
  • Facial swelling or hives.
  • Blood in vomit or stool.

What to tell or ask your vet today:

  • Is this medicine the right fit for my pet’s current symptoms?
  • Which warning signs mean I should call back right away?
  • How should I handle missed doses or refusal to take the medicine?

Next actions

Research brief

Medication Research Insights

A source-aware map of what to know, what is uncertain, and what to verify with your veterinarian.

Source Backed Signals

What to know

Evidence-backed context Limited

Roxee has limited cited overview evidence for Fenbendazole; use the official documents and your veterinarian's instructions for product-specific decisions.

Source: openFDA case USA-USFDACVM-2026-US-014359
Safety signal coverage Reported signals

32 tracked reaction signals; 32 reported cases; 21 serious reports; 2 species groups. These are reporting and label-derived signals for interpretation with a veterinarian.

Source: openFDA case USA-USFDACVM-2026-US-014359
Interpretation guardrail Not causation

Adverse-event reports help form a watch list, but they do not prove the medication caused the reaction and they are not a risk ranking between medications.

Evidence tension

Stronger signal Label / review

Official labels, package inserts, and reviewed summaries carry more weight than isolated reports.

Source: openFDA case USA-USFDACVM-2026-US-014359
Weaker signal Reported data

Case reports and openFDA terms are useful for pattern awareness, but they are incomplete, can include multiple exposures, and do not estimate an individual pet's probability of harm.

Reaction signal map

Most reported reactions Top terms

Unsteady walking (ataxia) (1 reports), Distension of abdomen (1 reports), Digestive tract neoplasm NOS (1 reports), Decreased red blood cell count (1 reports), Decreased percentage of reticulocytes (1 reports)

Body systems represented Signal grouping

Digestive (2), Skin & allergy (1), Neurologic (2), Behavior (1)

Explore supporting adverse reports

Species and breed lens

Species represented in reports Species lens

Dog (19 reports), Cat (13 reports)

Breed metadata in reports Metadata only

['Beagle', 'Dog (unknown)'] (2), Domestic Shorthair (2), ['Retriever - Golden', 'Poodle (unspecified)'] (1), Retriever - Labrador (1). These are report metadata, not proof that a breed is at higher risk.

What your vet may verify

Fit for this patient Vet check

Verify whether Fenbendazole fits the pet's species, current diagnosis, age, weight, organ status, pregnancy/lactation status, and concurrent medications.

Evidence limitations Evidence review

Separate label-backed warnings from adverse-event reports and owner observations before changing the plan.

What to watch next

Watch list Owner-safe

Sprinkle the appropriate amount of drug on a small amount of the usual grain ration, Prepare for each horse individually, Withholding feed or water is not necessary, Retreat in 6 to 8 weeks if required, Do not use in horses intended for food

Call sooner if Escalation

Repeated vomiting or diarrhea. Severe lethargy (hard to wake, very low energy). Collapse or fainting.

Bottom line: Use this Fenbendazole brief as a structured watch list and source map, not as a reason to start, stop, or change treatment without your veterinarian.
Vet source depth
  1. openFDA case USA-USFDACVM-2026-US-014359 · adverse_reaction · adverse reactions
  2. Contraindication source · fda_animal_drugs · warnings contraindications
  3. FDA application profile · official_label · quick facts
  4. FDA application profile · official_label · quick facts
  5. Medication usage source · fda_animal_drugs · quick facts
  6. FOI · document · documents
  7. FOI · document · documents
  8. SPL · document · documents

Evidence

Review status / Updated / Sources

Review status: Clinical reviewer not listed

Updated: February 12, 2026, 10:44 PM UTC

Sources:
Safety & side effects

Side effects to monitor:

  • Sprinkle the appropriate amount of drug on a small amount of the usual grain ration
  • Prepare for each horse individually
  • Withholding feed or water is not necessary
  • Retreat in 6 to 8 weeks if required
  • Do not use in horses intended for food

Most reported reactions:

  • Unsteady walking (ataxia) (1 reports)
  • Distension of abdomen (1 reports)
  • Digestive tract neoplasm NOS (1 reports)
Explore reported case details

Emergency warning signs:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.

Vet Fast Scan

Source-backed clinical checkpoints for quick review.

FDA-labeled species
Beef, Beef And Dairy, Boars, Breeders, Broilers, Dairy, Dog, Gilts, Growing, Horse, Layers, Non-Lactating, Pony, Pregnant sows, Replacements, Swine, Wild Animals, Zoo Animals
Indication / use
For the treatment and control of: Lungworms: Adult Dictyocaulus viviparus ; Stomach worms: Adult brown stomach worms ( Ostertagia ostertagi ), Adult and fourth stage larvae barber…
Form / route / dose
Form: Liquid (Suspension), Medicated Feed Block, Oral Suspension, Paste, Top Dressing In Feed, Type A Medicated Article
Route: Oral
Confirm product label and patient-specific plan.
Warnings
  • High: Sprinkle the appropriate amount of drug on a small amount of the usual grain ration. Prepare for each horse individuall…
Adverse-event caveat
openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.
Source docs

Quick Facts

Official label facts first, then secondary summaries. Marketing content is separated below.

Species: Both
Manufacturer: Multiple FDA labelers
Form: Liquid (Suspension), Medicated Feed Block, Oral Suspension, Paste, Top Dressing In Feed, Type A Medicated Article
Identifiers:
ANADA: 200831 NADA: 104494 NADA: 111278 NADA: 120648 NADA: 121473 NADA: 128620 NADA: 131675 NADA: 132872 NADA: 136116 NADA: 139189 NADA: 140954 NADA: 141144 NADA: 141449 NDC Package: 0061-1433-01 NDC Package: 0061-1433-02 NDC Package: 0061-1433-03 NDC Package: 43457-650-25 NDC Package: 49452-3035-1 NDC Package: 49452-3035-2 NDC Package: 49452-3035-3
Source metadata:

Warnings / Contraindications

Sprinkle the appropriate amount of drug on a small amount of the usual grain ration. Prepare for each horse individually. Withholding feed or water is not necessary. Retreat in 6 to 8 weeks if required. Do not use in horses intended for food. Consult your veterinarian assistance in the diagnosis, treatment, and control of parasitism. Do not use in horses intended for human consumption. Consult your veterinarian for assistance in the diagnosis, treatment and control of parasitism. Mix the appropriate amount of drug with a small amount of the usual food. Dry dog food may require slight moistening to facilitate mixing. Medicated food must be fully consumed.

  • High: Sprinkle the appropriate amount of drug on a small amount of the usual grain ration. Prepare for each horse individually. Withholding feed or water is not necessary. Retreat in 6 to 8 weeks if required. Do not use in horses intended for food. Consult your veterinarian assistance in the diagnosis, treatment, and control of parasitism. Do not use in horses intended for human consumption. Consult your veterinarian for assistance in the diagnosis, treatment and control of parasitism. Mix the appropriate amount of drug with a small amount of the usual food. Dry dog food may require slight moistening to facilitate mixing. Medicated food must be fully consumed.
Source metadata:

Adverse Reactions

Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.

Reported case explorer

Filter stored openFDA reports by pet and report attributes. Counts describe reports in this data set, not risk.

Clear filters
openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.
Stored reports
22
Matching reports
22
Active filters
0
Reset
Showing up to 50 matching reports.

USA-USFDACVM-2026-US-014244

Received 2026-03-25 · MSK · MSK

Non-serious
Species
Dog
Breed
['Beagle', 'Dog (unknown)']
Size / weight
25-49 lb (14.15 Kilogram)
Age
1-3 years (1 Year)
Sex
Male Neutered
Region
USA
Reactions
Lack of efficacy (endoparasite) - hookworm
Body systems
Effectiveness
Outcomes
Outcome Unknown

USA-USFDACVM-2026-US-014241

Received 2026-03-24 · MSK · MSK

Non-serious
Species
Dog
Breed
['Retriever - Golden', 'Poodle (unspecified)']
Size / weight
50-99 lb (27.699 Kilogram)
Age
4-7 years (5 Year)
Sex
Male Neutered
Region
USA
Reactions
Lack of efficacy (endoparasite) - hookwormLickingLocalised pain NOS (see other SOCs for specific pain)PododermatitisAllergy NOS
Body systems
EffectivenessOther
Outcomes
Outcome Unknown

USA-USFDACVM-2026-US-014167

Received 2026-03-19 · MSK · MSK

Non-serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
Under 10 lb (1.4 Kilogram)
Age
Under 1 year (11 Week)
Sex
Male Intact
Region
USA
Reactions
Soft stoolBloatedDisorder of gastrointestinal floraEmesis (multiple)DepressionIncreased heart rateBloody stoolBloody diarrhoea
Body systems
OtherDigestiveNeurologic
Outcomes
Recovered/Normal

USA-USFDACVM-2026-US-012371

Received 2026-03-17 · MSK · MSK

Non-serious
Species
Dog
Breed
Retriever - Labrador
Size / weight
50-99 lb (36.73 Kilogram)
Age
4-7 years (5 Year)
Sex
Female Neutered
Region
USA
Reactions
Lack of efficacy (endoparasite) - hookworm
Body systems
Effectiveness
Outcomes
Outcome Unknown

USA-USFDACVM-2026-US-014359

Received 2026-03-16 · MSK · MSK

Serious
Species
Dog
Breed
['Siberian Husky', 'Shepherd Dog - German']
Size / weight
50-99 lb (41.277 Kilogram)
Age
8+ years (9 Year)
Sex
Male Intact
Region
USA
Reactions
Other abnormal test result NOSLack of efficacy (endoparasite) - heartwormLethargy (see also Central nervous system depression in Neurological)Death by euthanasiaBlood in urineCloudy eye (for Miosis, Mydriasis, Anisocoria, Nystagmus - see Neurological)CoughSwelling NOSCorneal opacityUrine abnormalities NOSWeaknessIncreased lung soundsHaemolytic anaemiaNot eatingAbnormal breathingWalking difficultyDecreased red blood cell countDecreased percentage of reticulocytes
Body systems
OtherEffectivenessNeurologicSkin & allergy
Outcomes
Euthanized

USA-USFDACVM-2026-US-013526

Received 2026-03-13 · MSK · MSK

Non-serious
Species
Dog
Breed
['Beagle', 'Dog (unknown)']
Size / weight
25-49 lb (22.044 Kilogram)
Age
8+ years (8 Year)
Sex
Female Neutered
Region
USA
Reactions
Lack of efficacy (endoparasite) - roundworm NOSLack of efficacy (endoparasite) - hookwormExcessive appetiteAnal and rectal disorder NOS
Body systems
EffectivenessDigestiveOther
Outcomes
Ongoing

USA-USFDACVM-2026-US-008597

Received 2026-02-16 · MSK · MSK

Serious
Species
Dog
Breed
Crossbred Canine/dog
Age
Under 1 year (9 Week)
Sex
Male Intact
Region
USA
Reactions
Death by euthanasiaLack of efficacy (bacteria) - BordetellaSkin lumpDecreased haemoglobinHypokalaemiaDecreased haematocritOther abnormal test result NOSLow amylaseHyperproteinaemiaDecreased packed cell volume (PCV)Reduced globulinsEosinopeniaHyperphosphataemiaLow platelet countElevated creatine-kinase (CK)HypoproteinaemiaElevated creatinineElevated triglycerideHyperglycaemiaNeutrophiliaDecreased percentage of reticulocytesIncreased band neutrophiliaMonocytosisElevated serum alkaline phosphatase (ALP)Leukocytosis NOSElevated symmetrical dimethylarginine (SDMA)HypoalbuminaemiaElevated aspartate aminotransferase (AST)Elevated total bilirubinDecreased red blood cell countNeutropeniaLymphopeniaHypernatraemiaElevated C-reactive proteinElevated alanine aminotransferase (ALT)Elevated cholesterol (total)HyperchloraemiaElevated blood urea nitrogen (BUN)HypochloraemiaElevated lipaseDistension of abdomenLeukopenia NOS
Body systems
OtherEffectiveness
Outcomes
Euthanized

USA-USFDACVM-2026-US-007114

Received 2026-02-16 · MSK · MSK

Non-serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
Under 10 lb (2.72 Kilogram)
Age
Under 1 year (7 Month)
Sex
Male Neutered
Region
USA
Reactions
Hair loss NOS
Body systems
Skin & allergy
Outcomes
Outcome Unknown

USA-USFDACVM-2025-US-074155

Received 2025-12-16 · MSK · MSK

Serious
Species
Dog
Breed
Terrier - Yorkshire
Size / weight
Under 10 lb (0.395 Kilogram)
Age
Under 1 year (2 Month)
Sex
Female Intact
Region
USA
Reactions
ShakingHypersalivationLethargy (see also Central nervous system depression in Neurological)Head tremorAtaxiaNot eatingNot drinkingDry mucous membraneEosinophiliaThrombocytosisElevated gamma-glutamyl transferase (GGT)HypoglycaemiaHypokalaemiaSeizure NOS
Body systems
OtherDigestiveNeurologic
Outcomes
Ongoing

USA-USFDACVM-2025-US-074732

Received 2025-12-11 · MSK · MSK

Non-serious
Species
Dog
Breed
Hound (unspecified)
Size / weight
50-99 lb (23.133 Kilogram)
Age
1-3 years (3 Year)
Sex
Male Neutered
Region
USA
Reactions
Lack of efficacy (endoparasite) - tapeworm
Body systems
Effectiveness
Outcomes
Outcome Unknown

USA-USFDACVM-2025-US-073892

Received 2025-12-11 · MSK · MSK

Non-serious
Species
Dog
Size / weight
50-99 lb (29.3 Kilogram)
Age
8+ years (8.07 Year)
Sex
Female Neutered
Region
USA
Reactions
Lack of efficacy (endoparasite) - heartwormWeight fluctuation
Body systems
EffectivenessOther
Outcomes
Ongoing

USA-USFDACVM-2025-US-073022

Received 2025-12-11 · MSK · MSK

Serious
Species
Dog
Breed
Greyhound
Size / weight
50-99 lb (40.823 Kilogram)
Age
8+ years (11 Year)
Sex
Male Neutered
Region
USA
Reactions
Lack of efficacy (endoparasite) - hookworm
Body systems
Effectiveness
Outcomes
Ongoing

USA-USFDACVM-2025-US-073011

Received 2025-12-11 · MSK · MSK

Serious
Species
Dog
Breed
Greyhound
Size / weight
50-99 lb (33.566 Kilogram)
Age
1-3 years (3 Year)
Sex
Male Neutered
Region
USA
Reactions
Lack of efficacy (endoparasite) - hookwormMedication error NOSDrug dose administration interval too short
Body systems
EffectivenessOther
Outcomes
Ongoing

USA-USFDACVM-2025-US-072921

Received 2025-12-11 · MSK · MSK

Serious
Species
Dog
Breed
Greyhound
Size / weight
50-99 lb (29.937 Kilogram)
Age
4-7 years (7 Year)
Sex
Female Neutered
Region
USA
Reactions
Lack of efficacy (endoparasite) - hookwormMedication error NOSDrug dose administration interval too shortOverdose
Body systems
EffectivenessOther
Outcomes
Ongoing

USA-USFDACVM-2025-US-072673

Received 2025-12-04 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
Under 10 lb (0.699 Kilogram)
Age
Under 1 year (1 Month)
Sex
Female Unknown
Region
USA
Reactions
DeathMedication error NOS
Body systems
Other
Outcomes
Died

USA-USFDACVM-2025-US-071202

Received 2025-12-02 · MSK · MSK

Non-serious
Species
Dog
Breed
Catahoula Leopard Dog
Size / weight
50-99 lb (28.803 Kilogram)
Age
4-7 years (6 Year)
Sex
Female Neutered
Region
USA
Reactions
Pica NOSDiarrhoeaBloody stoolWeight loss
Body systems
OtherDigestive
Outcomes
Ongoing

USA-USFDACVM-2025-US-070191

Received 2025-11-21 · MSK · MSK

Non-serious
Species
Dog
Breed
['Terrier (unspecified)', 'Dog (unknown)']
Size / weight
10-24 lb (5.987 Kilogram)
Age
Under 1 year (5 Month)
Sex
Female Unknown
Region
USA
Reactions
AlopeciaBacterial skin infection NOSRingwormVomitingCoughBloody diarrhoeaBehavioural disorder NOSLack of efficacy (bacteria) - Anaplasma
Body systems
Skin & allergyOtherDigestiveBehaviorEffectiveness
Outcomes
Outcome Unknown

USA-USFDACVM-2025-US-070682

Received 2025-11-18 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Mediumhair
Size / weight
10-24 lb (4.82 Kilogram)
Age
4-7 years (6.08 Year)
Sex
Female Neutered
Region
USA
Reactions
FibrosarcomaDecreased activityHissingInjection site lumpBehavioural disorder NOSTooth disorderGingivitisNeoplasia NOSLeucocytosis NOSSkin inflammation NOSAbnormal radiograph findingAbnormal cytology
Body systems
OtherBehavior
Outcomes
Outcome Unknown

USA-USFDACVM-2025-US-069347

Received 2025-11-14 · MSK · MSK

Non-serious
Species
Dog
Breed
Shepherd Dog - Australian
Age
Under 1 year (3 Month)
Sex
Female Intact
Region
USA
Reactions
Lack of efficacy (endoparasite) - hookwormDiarrhoeaEmesis (multiple)
Body systems
EffectivenessDigestive
Outcomes
Outcome Unknown

USA-USFDACVM-2025-US-069852

Received 2025-11-06 · MSK · MSK

Non-serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
Under 10 lb (0.52 Kilogram)
Age
Under 1 year (2 Month)
Sex
Female Intact
Region
USA
Reactions
HepatomegalyAbnormal radiograph findingHypothermiaWeight lossSicknessVomiting
Body systems
OtherDigestive
Outcomes
Ongoing

USA-USFDACVM-2025-US-064224

Received 2025-10-31 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Longhair
Size / weight
Under 10 lb (0.39 Kilogram)
Age
Under 1 year (7 Week)
Sex
Female Intact
Region
USA
Reactions
DeathLethargy (see also Central nervous system depression in Neurological)Reluctant to moveDecreased body temperatureHypoglycaemiaDecreased packed cell volume (PCV)Head downNystagmus
Body systems
OtherNeurologic
Outcomes
Died

USA-USFDACVM-2025-US-062768

Received 2025-10-17 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
Under 10 lb (0.52 Kilogram)
Age
Under 1 year (2 Month)
Sex
Female Intact
Region
USA
Reactions
Lack of efficacy - NOSIntentional misuseHepatomegalyAbnormal radiograph findingHypothermiaWeight loss
Body systems
EffectivenessOther
Outcomes
Ongoing

Tap or hover a reaction to see what it means in plain language.

Tracked signals
32
Reported cases
32
Serious reports
21
Species represented
2
Grouped by Body System
Digestive (2) · Diarrhea, Bloody diarrhoea Skin & allergy (1) · Hair loss Neurologic (2) · Unsteady walking (ataxia), Depression Behavior (1) · Behavioral disorder (unspecified) Other (26) · Distension of abdomen, Disorder of gastrointestinal flora, Digestive tract neoplasm NOS
Most Reported Reactions
Reaction Body system Cases Species Serious cases
Neurologic 1 Dog 1
Other 1 Dog 1
Other 1 Cat 1
Other 1 Dog 1
Other 1 Dog 1
Other 1 Cat 1
Other 1 Dog 1
Other 1 Dog 1

Species coverage: Dog (19) Cat (13)

View detailed reaction table
Reaction Body system Species Seriousness Frequency Reports
Neurologic Dog Serious - 1
Skin & allergy Dog Non-serious - 1
Other Dog Serious - 1
Other Cat Non-serious - 1
Other Cat Serious - 1
Digestive Dog Non-serious - 1
Neurologic Cat Non-serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Dog Non-serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Non-serious - 1
Digestive Dog Non-serious - 1
Other Dog Serious - 1
Other Cat Non-serious - 1
Behavior Cat Serious - 1
Other Dog Non-serious - 1
Other Dog Non-serious - 1
Other Cat Serious - 1
Other Dog Non-serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Source metadata:

Source Documents

The most useful source links appear first; full previews and metadata stay in the veterinary/professional layer.

Use original documents to confirm product-specific warnings, ingredients, and handling details with your veterinarian.

Full source previews and metadata remain in the veterinary/professional layer.

Owner handouts

0
No owner handouts linked yet.

Official label / PI

14

SPL

25

FOI

26

131-675

Official label / PI · EA

131-675

Official label / PI · FONSI

131-675

Official label / PI · EA

131-675

Official label / PI · FONSI

132-872

Official label / PI · EA

132-872

Official label / PI · FONSI

128-620

Official label / PI · EA

128-620

Official label / PI · FONSI

141-449

Official label / PI · EA

141-449

Official label / PI · FONSI

141-449

Official label / PI · EA

141-449

Official label / PI · FONSI

141-449

Official label / PI · EA

141-449

Official label / PI · FONSI

Safe-Guard®

SPL · SPL

FDA Structured Product Label

Safe-Guard® Safe-Guard® EnProAl®

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Intervet, Inc.
NADA
139-189
Status
OTC
Form
Medicated Feed Block
Route
Oral
Species
Beef
Composition / specifications
Each pound of molasses block contains 750 milligrams of fenbendazole. Each pound of protein block contains 750 milligrams of fenbendazole.

Cattle (beef)

Indication

For the treatment and control of: Lungworms: Adult Dictyocaulus viviparus; Stomach worms: Adult brown stomach worms (Ostertagia ostertagi), Adult and fourth stage larvae barberpole worms (Haemonchus contortus), fourth stage larvae barberpole worms (H. placei), and Adult and fourth stage larvae small stomach worms (Trichostrongylus axei); Intestinal worms (Adult and fourth stage larvae): hookworms (Bunostomum phlebotomum), thread-necked intestinal worms (Nematodirus helvetianus), small intestinal worms (Cooperia punctata & C. oncophora), bankrupt worms (Trichostrongylus colubriformis), and nodular worms (Oesophagostomum radiatum).

Dosage

Feed free-choice at a rate of 0.1 pound of block per 100 lb body weight (BW) per day for 3 days to deliver a total of 2.27 mg fenbendazole/lb BW (5 mg/kg BW). Do not underdose. Ensure each animal receives a complete dose based on a current body weight. Underdosing may result in ineffective treatment, and encourage the development of parasite resistance. Consult a veterinarian for assistance in the diagnosis, treatment, and control of parasitism.

Limitations

Administer free choice of beef cattle on pasture that have become accustomed to non-medicated block feeding during an adaptation period of 12 to 19 days. Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism.

Safe-Guard®

SPL · SPL

FDA Structured Product Label

Safe-Guard®

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Intervet, Inc.
NADA
131-675
Status
OTC
Form
Type A Medicated Article
Route
Oral
Species
Gilts • Growing • Pregnant sows • Boars • Beef And Dairy • Zoo Animals • Swine • Wild Animals
Composition / specifications
Type A medicated articles conatianing 4 percent (18.1 grams per pound), 8 percent (36.2 grams per pound), and 20 percent (90.7 grams per pound) fenbendazole.

Bighorn sheep

Indication

For the treatment and control of: Lungworms (Protostrongylus spp.).

Dosage

10 mg fenbendazole/kg body weight/day x 3 days of treatment

Feral Swine

Indication

For the treatment and control of: kidney worms (Stephanurus dentatus), roundworms (Ascaris suum), and nodular worms (Oesophagostomum dentatum).

Dosage

3 mg fenbendazole/kg body weight/day x 3 days of treatment

Wildlife and Zoo Ruminants (Subfamily Antilopinae, Hippotraginae, and Caprinae)

Indication

For the treatment and control of: Stomach worms: small stomach worms (Trichostrongylus spp.), barberpole worms (Haemonchus spp.); Intestinal worms: thread-necked intestinal worms (Nematodirus spp.) and whipworms (Trichuris spp.)

Dosage

2.5 mg fenbendazole/kg body weight/day x 3 days of treatment

Growing Turkeys

Indication

For the treatment and control of: Gastrointestinal worms: Roundworms, Adults and larvae (Ascaridia dissimilis); Cecal worms, Adults and larvae (Heterakis gallinarum), an important vector of Histomonas meleagridis (Blackhead).

Dosage

14.5 g fenbendazole/ton of feed, to be fed as the sole ration for 6 days

Swine (Growing pigs, gilts, pregnant sows, and boars)

Indication

For the treatment and control of: Lungworms: Adult Metastrongylus apri, adult Metastrongylus pudendotectus; Gastrointestinal worms: Adult and larvae (L3, L4 stages, liver, lung, intestinal forms) large roundworms (Ascaris suum), Adult nodular worms (Oesophagostomum dentatum, O. quadrispinulatum), Adult small stomach worms (Hyostrongylus rubidus), Adult and larvae (L2, L3, L4 stages- intestinal mucosal forms) whipworms (Trichuris suis); and Kidney worms: Adult and larvae Stephanurus dentatus.

Dosage

9 mg fenbendazole per kg body weight (4.08 mg fenbendazole per pound) to be fed as the sole ration over a period of 3 to 12 days.

Cattle (Dairy and Beef Cattle)

Indication

For the treatment and control of: Lungworms: Adult Dictyocaulus viviparus; Stomach worms: Adult brown stomach worms (Ostertagia ostertagi), Adult and fourth stage larvae barberpole worms (Haemonchus contortus), fourth stage larvae barberpole worms (H. placei), and Adult and fourth stage larvae small stomach worms (Trichostrongylus axei); Intestinal worms (Adult and fourth stage larvae): hookworms (Bunostomum phlebotomum), thread-necked intestinal worms (Nematodirus helvetianus), small intestinal worms (Cooperia punctata & C. oncophora), bankrupt worms (Trichostrongylus colubriformis), and nodular worms (Oesophagostomum radiatum)

Dosage

5 mg fenbendazole per kg body weight in a one (1) day treatment (2.27 mg fenbendazole per pound). Feed as the sole ration for one (1) day. Free-Choice Feeds: Type C free-choice medicated feed must be manufactured by a licensed feed mill according to an approved formula to provide a total of 5 mg per kg body weight fenbendazole over 3 to 6 days.

Horses

Indication

For the treatment and control of: Large strongyles (Strongylus edentatus, S. equinus, S. vulgaris, Triodontophorus spp.), Small strongyles (Cyathostomum spp., Cylicocyclus spp., Cylicostephanus spp.), Pinworms (Oxyuris equi), and Ascarids (Parascaris equorum).

Dosage

For the control of large strongyles, small strongyles, and pinworms the recommended dose is 5 mg fenbendazole per kg body weight (2.27 mg fenbendazole per pound) in a one (1) day treatment. For the control of ascarids the recommended dose is 10 mg fenbendazole per kg body weight (4.54 mg fenbendazole per pound) in a one (1) day treatment.

Wild quail

Indication

For the treatment and control of Gastrointestinal worms: Cecal worms, (Aulonocephalus spp.).

Dosage

90.7 g of fenbendazole/ton of Type C medicated feed, to be fed for 21 consecutive days.

Defendazole™

SPL · SPL

FDA Structured Product Label

Defendazole™

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Norbrook Laboratories, Ltd.
ANADA
200-831
Status
OTC
Form
Oral Suspension
Route
Oral
Species
Beef And Dairy
Composition / specifications
100 mg/mL (10%)

Beef and Dairy Cattle

Indication

For the treatment and control of:
Lungworms: Adult Dictyocaulus viviparus;
Stomach worms: Adult brown stomach worms (Ostertagia ostertagi), Adult and fourth stage larvae barberpole worms (Haemonchus contortus & H. placei), and Adult and fourth stage larvae small stomach worms (Trichostrongylus axei);
Intestinal worms (Adult and fourth stage larvae): hookworms (Bunostomum phlebotomum), thread-necked intestinal worms (Nematodirus helvetianus), small intestinal worms (Cooperia punctata & C. oncophora), bankrupt worms (Trichostrongylus colubriformis), and nodular worms (Oesophagostomum radiatum).

Dosage

2.3 mg/lb (5 mg/kg) body weight

Goats

Indication

For the treatment and control of:
Stomach worms (adults): Haemonchus contortus and Teladorsagia circumcincta.

Dosage

2.3 mg/lb (5 mg/kg) body weight

Safe-Guard®

SPL · SPL

FDA Structured Product Label

Safe-Guard®

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Intervet, Inc.
NADA
132-872
Status
OTC
Form
Paste
Route
Oral
Species
Beef • Dairy
Composition / specifications
The product is an aqueous paste containing 10 percent fenbendazole.

Beef and dairy cattle

Indication

For the treatment and control of: Lungworms: Adult Dictyocaulus viviparus; Stomach worms: Adult brown stomach worms (Ostertagia ostertagi), Adult and fourth stage larvae barberpole worms (Haemonchus contortus), fourth stage larvae barberpole worms (H. placei), and Adult and fourth stage larvae small stomach worms (Trichostrongylus axei); Intestinal worms (Adult and fourth stage larvae): hookworms (Bunostomum phlebotomum), thread-necked intestinal worms (Nematodirus helvetianus), small intestinal worms (Cooperia punctata & C. oncophora), bankrupt worms (Trichostrongylus colubriformis), and nodular worms (Oesophagostomum radiatum).

Dosage
Administer orally 5 milligrams per kilogram of body weight (2.3 milligrams per pound).
Limitations

Do not underdose. Ensure each animal receives a complete dose based on a current body weight. Underdosing may result in ineffective treatment, and encourage the development of parasite resistance. Consult a veterinarian for assistance in the diagnosis, treatment, and control of parasitism.

Safe-Guard®

SPL · SPL

FDA Structured Product Label

Safe-Guard® Panacur®

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Intervet, Inc.
NADA
128-620
Status
OTC
Form
Liquid (Suspension)
Route
Oral
Species
Non-Lactating • Beef • Dairy
Composition / specifications
The drug is a suspension containing 10 percent (100 milligrams per milliliter) fenbendazole.

Cattle (beef and dairy)

Indication

For the treatment and control of: Lungworms: Adult Dictyocaulus viviparus; Stomach worms: Adult brown stomach worms (Ostertagia ostertagi), Adult and fourth stage larvae barberpole worms (Haemonchus contortus & H. placei), and Adult and fourth stage larvae small stomach worms (Trichostrongylus axei); Intestinal worms (Adult and fourth stage larvae): hookworms (Bunostomum phlebotomum), thread-necked intestinal worms (Nematodirus helvetianus), small intestinal worms (Cooperia punctata & C. oncophora), bankrupt worms (Trichostrongylus colubriformis), and nodular worms (Oesophagostomum radiatum).

Dosage

Administer orally at a dose of 2.3 mg/lb (5 mg/kg) body weight.

Goats

Indication

For the treatment and control of: Stomach worms (adults): Haemonchus contortus and Teladorsagia circumcincta.

Dosage

Administer orally at a dose of 2.3 mg/lb (5 mg/kg) body weight.

Panacur®

SPL · SPL

FDA Structured Product Label

Safe-Guard® Panacur®

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Intervet, Inc.
NADA
128-620
Status
OTC
Form
Liquid (Suspension)
Route
Oral
Species
Non-Lactating • Beef • Dairy
Composition / specifications
The drug is a suspension containing 10 percent (100 milligrams per milliliter) fenbendazole.

Cattle (beef and dairy)

Indication

For the treatment and control of: Lungworms: Adult Dictyocaulus viviparus; Stomach worms: Adult brown stomach worms (Ostertagia ostertagi), Adult and fourth stage larvae barberpole worms (Haemonchus contortus & H. placei), and Adult and fourth stage larvae small stomach worms (Trichostrongylus axei); Intestinal worms (Adult and fourth stage larvae): hookworms (Bunostomum phlebotomum), thread-necked intestinal worms (Nematodirus helvetianus), small intestinal worms (Cooperia punctata & C. oncophora), bankrupt worms (Trichostrongylus colubriformis), and nodular worms (Oesophagostomum radiatum).

Dosage

Administer orally at a dose of 2.3 mg/lb (5 mg/kg) body weight.

Goats

Indication

For the treatment and control of: Stomach worms (adults): Haemonchus contortus and Teladorsagia circumcincta.

Dosage

Administer orally at a dose of 2.3 mg/lb (5 mg/kg) body weight.

safe-guard®

SPL · SPL

FDA Structured Product Label

safe-guard® panacur®

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Intervet, Inc.
NADA
120-648
Status
OTC
Form
Paste
Route
Oral
Species
Horse • Pony
Composition / specifications
The product is an aqueous paste containing 10 percent fenbendazole.

Horses

Indication

For the treatment and control of large strongyles (Strongylus edentatus, S. equinus, S. vulgaris), encysted early 3rd stage (hypobiotic), late 3rd stage and 4th stage cyathostome larvae, small strongyles, pinworms (Oxyuris equi), ascarids (Parascaris equorum), and for the control of arteritis caused by 4th stage larvae of Strongylus vulgaris in horses.

Dosage

For large strongyles, small strongyles, and pinworms, the recommended dose is 5 mg/kg (2.3 mb/lb) administered once orally. For ascarids, the recommended dose is 10 mg/kg (4.6 mg/lb) administered once orally. For treatment and control of hypobiotic (encysted early 3rd stage), late 3rd stage, and 4th stage cyathostome larvae, as well as 4th stage Strongylus vulgaris larvae, the recommended dose is 10 mg/kg (4.6 mg/lb) administered orally daily for 5 consecutive days.

Limitations

Do not use in horses intended for human consumption. Consult your veterinarian for assistance in the diagnosis, treatment and control of parasitism.

panacur®

SPL · SPL

FDA Structured Product Label

safe-guard® panacur®

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Intervet, Inc.
NADA
120-648
Status
OTC
Form
Paste
Route
Oral
Species
Horse • Pony
Composition / specifications
The product is an aqueous paste containing 10 percent fenbendazole.

Horses

Indication

For the treatment and control of large strongyles (Strongylus edentatus, S. equinus, S. vulgaris), encysted early 3rd stage (hypobiotic), late 3rd stage and 4th stage cyathostome larvae, small strongyles, pinworms (Oxyuris equi), ascarids (Parascaris equorum), and for the control of arteritis caused by 4th stage larvae of Strongylus vulgaris in horses.

Dosage

For large strongyles, small strongyles, and pinworms, the recommended dose is 5 mg/kg (2.3 mb/lb) administered once orally. For ascarids, the recommended dose is 10 mg/kg (4.6 mg/lb) administered once orally. For treatment and control of hypobiotic (encysted early 3rd stage), late 3rd stage, and 4th stage cyathostome larvae, as well as 4th stage Strongylus vulgaris larvae, the recommended dose is 10 mg/kg (4.6 mg/lb) administered orally daily for 5 consecutive days.

Limitations

Do not use in horses intended for human consumption. Consult your veterinarian for assistance in the diagnosis, treatment and control of parasitism.

Panacur® C (OTC)

SPL · SPL

FDA Structured Product Label

Panacur® C (OTC) Safe-Guard® Canine (OTC) Panacur® Granules 22.2% (Rx)

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Intervet, Inc.
NADA
121-473
Status
OTC
Form
Top Dressing In Feed
Route
Oral
Species
Dog
Composition / specifications
The drug is in granular form containing 22 percent (222 milligrams per gram) fenbendazole.

Dogs

Indication
For the treatment and control of ascarids (Toxocara canis, Toxascaris leonina), hookworms (Ancylostoma caninum, Uncinaria stenocephala), whipworms (Trichuris vulpis), and tapeworms (Taenia pisiformis).
Dosage
50 milligrams per kilogram (22.7 milligrams per pound) daily for 3 consecutive days.
Limitations

Mix the appropriate amount of drug with a small amount of the usual food. Dry dog food may require slight moistening to facilitate mixing. Medicated food must be fully consumed. 

Safe-Guard® Canine (OTC)

SPL · SPL

FDA Structured Product Label

Panacur® C (OTC) Safe-Guard® Canine (OTC) Panacur® Granules 22.2% (Rx)

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Intervet, Inc.
NADA
121-473
Status
OTC
Form
Top Dressing In Feed
Route
Oral
Species
Dog
Composition / specifications
The drug is in granular form containing 22 percent (222 milligrams per gram) fenbendazole.

Dogs

Indication
For the treatment and control of ascarids (Toxocara canis, Toxascaris leonina), hookworms (Ancylostoma caninum, Uncinaria stenocephala), whipworms (Trichuris vulpis), and tapeworms (Taenia pisiformis).
Dosage
50 milligrams per kilogram (22.7 milligrams per pound) daily for 3 consecutive days.
Limitations

Mix the appropriate amount of drug with a small amount of the usual food. Dry dog food may require slight moistening to facilitate mixing. Medicated food must be fully consumed. 

Panacur® Granules 22.2% (Rx)

SPL · SPL

FDA Structured Product Label

Panacur® C (OTC) Safe-Guard® Canine (OTC) Panacur® Granules 22.2% (Rx)

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Intervet, Inc.
NADA
121-473
Status
OTC
Form
Top Dressing In Feed
Route
Oral
Species
Dog
Composition / specifications
The drug is in granular form containing 22 percent (222 milligrams per gram) fenbendazole.

Dogs

Indication
For the treatment and control of ascarids (Toxocara canis, Toxascaris leonina), hookworms (Ancylostoma caninum, Uncinaria stenocephala), whipworms (Trichuris vulpis), and tapeworms (Taenia pisiformis).
Dosage
50 milligrams per kilogram (22.7 milligrams per pound) daily for 3 consecutive days.
Limitations

Mix the appropriate amount of drug with a small amount of the usual food. Dry dog food may require slight moistening to facilitate mixing. Medicated food must be fully consumed. 

Safe-Guard® AquaSol

SPL · SPL

FDA Structured Product Label

Safe-Guard® AquaSol

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Intervet, Inc.
NADA
141-449
Status
OTC
Form
Oral Suspension
Route
Oral
Species
Swine • Breeders • Broilers • Layers • Replacements
Composition / specifications
200 mg/mL

Swine (Except Nursing Piglets)

Indication

For the treatment and control of: Lungworms: Adult Metastrongylus apri, adult Metastrongylus pudendotectus; Gastrointestinal worms: Adult and larvae (L3, L4 stages, liver, lung, intestinal forms) large roundworms (Ascaris suum), Adult nodular worms (Oesophagostomum dentatum, O. quadrispinulatum), Adult small stomach worms (Hyostrongylus rubidus), Adult and larvae (L2, L3, L4 stages- intestinal mucosal forms) whipworms (Trichuris suis); and Kidney worms: Adult and larvae Stephanurus dentatus.

Dosage
2.2 mg fenbendazole/kg body weight (BW) (1 mg/lb) daily for 3 consecutive days

Chickens (broilers, replacements, breeding, and laying hens)

Indication

For the treatment and control of adult Ascaridia galli in broiler chickens and replacement chickens and for the treatment and control of adult A. galli and Heterakis gallinarum in breeding chickens and laying hens.

Dosage
1 mg/kg BW (0.454 mg/lb)/day for 5 consecutive days

Ozipco SPL

SPL · Structured Product Label

FDA Structured Product Label XML for Ozipco. Use the source link for the full official labeling record.

Panacur SPL

SPL · Structured Product Label

FDA Structured Product Label XML for Panacur. Use the source link for the full official labeling record.

Panacur SPL

SPL · Structured Product Label

FDA Structured Product Label XML for Panacur. Use the source link for the full official labeling record.

Panacur SPL

SPL · Structured Product Label

FDA Structured Product Label XML for Panacur. Use the source link for the full official labeling record.

Panacur SPL

SPL · Structured Product Label

FDA Structured Product Label XML for Panacur. Use the source link for the full official labeling record.

Panacur C Canine SPL

SPL · Structured Product Label

FDA Structured Product Label XML for Panacur C Canine. Use the source link for the full official labeling record.

Safe-guard SPL

SPL · Structured Product Label

FDA Structured Product Label XML for Safe-guard. Use the source link for the full official labeling record.

Safe-Guard SPL

SPL · Structured Product Label

FDA Structured Product Label XML for Safe-Guard. Use the source link for the full official labeling record.

Safe-guard SPL

SPL · Structured Product Label

FDA Structured Product Label XML for Safe-guard. Use the source link for the full official labeling record.

Safe-Guard AquaSol SPL

SPL · Structured Product Label

FDA Structured Product Label XML for Safe-Guard AquaSol. Use the source link for the full official labeling record.

Defendazole SPL

SPL · Structured Product Label

FDA Structured Product Label XML for Defendazole. Use the source link for the full official labeling record.

Safe-Guard SPL

SPL · Structured Product Label

FDA Structured Product Label XML for Safe-Guard. Use the source link for the full official labeling record.

Safe-Guard SPL

SPL · Structured Product Label

FDA Structured Product Label XML for Safe-Guard. Use the source link for the full official labeling record.

FOI Summary sN 139-189 Approved April 26, 2021.pdf

FOI · FOI

UCM472706.pdf

FOI · FOI

FOI Summary sN 131-675 Approved May 23, 2024.pdf

FOI · FOI

FOI Summary sN 131-675 Approved January 10, 2022.pdf

FOI · FOI

UCM364715.pdf

FOI · FOI

ucm069865.pdf

FOI · FOI

ucm069862.pdf

FOI · FOI

ucm069858.pdf

FOI · FOI

N131675_Supp_03_30_1991.pdf

FOI · FOI

UCM470924.pdf

FOI · FOI

FOI Summary oA 200-831 Approved January 13, 2026.pdf

FOI · FOI

FOI Summary sN 132-872 Approved March 24, 2021.pdf

FOI · FOI

N-132872-Q-0140-OT-AA_foi.pdf

FOI · FOI

FOI Summary sN 128-620 Approved June 14, 2021.pdf

FOI · FOI

ucm069824.pdf

FOI · FOI

ucm069823.pdf

FOI · FOI

N-128620-Q-0179-OT-AA_foi.pdf

FOI · FOI

N128620_Supp_04_25_1994.pdf

FOI · FOI

N120648_Supp_May_28_1985.pdf

FOI · FOI

ucm069818.pdf

FOI · FOI

N121473_Suppl_5_31_1994.pdf

FOI · FOI

FOI Summary sN 141-449 Approved January 5, 2018.pdf

FOI · FOI

UCM488824.pdf

FOI · FOI

UCM471258.pdf

FOI · FOI

ucm117184.pdf

FOI · FOI summary

UCM478252.pdf

FOI · FOI summary

Veterinary reference (advanced)

Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.

At a Glance

Quick facts and links to official labeling and safety signals.

Data freshness
  • Reference facts: Source Roxee | Refreshed Aug 6, 2026, 7:47 PM UTC
    The reference fact projection used for browse cards and quick facts.
  • Animal Drugs @ FDA: Source FDA | Refreshed Aug 6, 2026, 7:47 PM UTC
    Applications/products are imported from FDA export data.
  • Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
    Label highlights/doc links are fetched from FDA preview endpoints.
  • openFDA reaction terms: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
Official (FDA)
Identity: Generic ingredient • No FDA branded products linked
No official FDA brand rows linked yet for this ingredient.
Manufacturer mapping: Multiple FDA labelers
Case-reported brands (openFDA): MSK
Catalog species: Both FDA-labeled species: Beef, Beef And Dairy, Boars, Breeders, Broilers, Dairy, Dog, Gilts, Growing, Horse, Layers, Non-Lactating, Pony, Pregnant sows, Replacements, Swine, Wild Animals, Zoo Animals
Rx/OTC: OTC
Form/route: Liquid (Suspension), Medicated Feed Block, Oral Suspension, Paste, Top Dressing In Feed, Type A Medicated Article Oral
Applications: NADA 139-189 • NADA 131-675 • ANADA 200-831 • NADA 132-872 • NADA 128-620 • NADA 120-648 • NADA 121-473 • NADA 141-449
Documents: 38 (FOI: 24) • SPL: 12 Label highlights Official documents
Safety (openFDA)
Top reactions: Dog 92 Cat 37 View
Case summaries: 22 (showing 8) View
openFDA reports are unverified and do not prove causation.

Explore
Related conditions: Gastrointestinal (additional)
Linked using: Fda_Label (0.95)

Diagnosis Codes

Diagnosis-code mappings are not available for this medication yet.

Counseling and Monitoring Highlights

Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.

Owner-facing counseling points
  • Sprinkle the appropriate amount of drug on a small amount of the usual grain ration. Prepare for each horse individually. Withholding feed or water is not necessary. Retreat in 6 to 8 weeks if required. Do not use in horses intended for food. Consult your veterinarian assistance in the diagnosis, treatment, and control of parasitism. Do not use in horses intended for human consumption. Consult your veterinarian for assistance in the diagnosis, treatment and control of parasitism. Mix the appropriate amount of drug with a small amount of the usual food. Dry dog food may require slight moistening to facilitate mixing. Medicated food must be fully consumed. (Contraindication, High)
Top reaction signals
Unsteady walking (ataxia) (1) Distension of abdomen (1) Digestive tract neoplasm NOS (1) Decreased red blood cell count (1) Decreased percentage of reticulocytes (1) Decreased packed cell volume (1) Decreased haemoglobin (1) Decreased haematocrit (1)

Identifiers & Packages

Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.

Identifiers
ANADA: 200831 NADA: 104494 NADA: 111278 NADA: 120648 NADA: 121473 NADA: 128620 NADA: 131675 NADA: 132872 NADA: 136116 NADA: 139189 NADA: 140954 NADA: 141144 NADA: 141449 NDC Package: 0061-1433-01 NDC Package: 0061-1433-02 NDC Package: 0061-1433-03 NDC Package: 43457-650-25 NDC Package: 49452-3035-1 NDC Package: 49452-3035-2 NDC Package: 49452-3035-3 NDC Package: 49452-3035-4 NDC Package: 49452-3035-5 NDC Package: 49452-3035-6 NDC Package: 55529-165-06
Package NDC Product NDC Form / Route Status
0061-1433-01 0061 -
0061-1433-02 0061 -
0061-1433-03 0061 -
43457-650-25 43457 -
49452-3035-1 49452 -
49452-3035-2 49452 -
49452-3035-3 49452 -
49452-3035-4 49452 -
49452-3035-5 49452 -
49452-3035-6 49452 -
55529-165-06 55529 -
55529-165-08 55529 -
57926-081-44 57926 -
57926-081-48 57926 -
57926-083-44 57926 -
57926-084-46 57926 -
57926-085-47 57926 -
57926-086-01 57926 -
57926-087-01 57926 -
57926-088-01 57926 -

Enriched Documents

Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.

  • Ozipco SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Panacur SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Panacur SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Panacur SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Panacur SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Panacur C Canine SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Safe-guard SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Safe-Guard SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Safe-guard SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Safe-Guard AquaSol SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Defendazole SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Safe-Guard SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Safe-Guard SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • UCM472706.pdf • FOI summary • Official • April 28, 2026
    FDA FOI summary for application 139189
  • FOI Summary sN 139-189 Approved April 26, 2021.pdf • FOI summary • Official • April 28, 2026
    FDA FOI summary for application 139189
  • UCM470924.pdf • FOI summary • Official • April 10, 2026
    FDA FOI summary for application 131675
  • N131675_Supp_03_30_1991.pdf • FOI summary • Official • April 10, 2026
    FDA FOI summary for application 131675
  • ucm069858.pdf • FOI summary • Official • April 10, 2026
    FDA FOI summary for application 131675
  • ucm069862.pdf • FOI summary • Official • April 10, 2026
    FDA FOI summary for application 131675
  • ucm069865.pdf • FOI summary • Official • April 10, 2026
    FDA FOI summary for application 131675
  • UCM364715.pdf • FOI summary • Official • April 10, 2026
    FDA FOI summary for application 131675
  • FOI Summary sN 131-675 Approved January 10, 2022.pdf • FOI summary • Official • April 10, 2026
    FDA FOI summary for application 131675
  • FOI Summary sN 131-675 Approved May 23, 2024.pdf • FOI summary • Official • April 10, 2026
    FDA FOI summary for application 131675
  • FOI Summary oA 200-831 Approved January 13, 2026.pdf • FOI summary • Official • Feb. 2, 2026
    FDA FOI summary for application 200831
  • ucm117184.pdf • FOI summary • Official • Nov. 12, 2024
    FDA FOI summary for application 141144
  • N-132872-Q-0140-OT-AA_foi.pdf • FOI summary • Official • Oct. 12, 2023
    FDA FOI summary for application 132872
  • FOI Summary sN 132-872 Approved March 24, 2021.pdf • FOI summary • Official • Oct. 12, 2023
    FDA FOI summary for application 132872
  • UCM478252.pdf • FOI summary • Official • Aug. 25, 2023
    FDA FOI summary for application 140954
  • N128620_Supp_04_25_1994.pdf • FOI summary • Official • June 6, 2022
    FDA FOI summary for application 128620
  • N-128620-Q-0179-OT-AA_foi.pdf • FOI summary • Official • June 6, 2022
    FDA FOI summary for application 128620
  • ucm069823.pdf • FOI summary • Official • June 6, 2022
    FDA FOI summary for application 128620
  • ucm069824.pdf • FOI summary • Official • June 6, 2022
    FDA FOI summary for application 128620
  • FOI Summary sN 128-620 Approved June 14, 2021.pdf • FOI summary • Official • June 6, 2022
    FDA FOI summary for application 128620
  • N120648_Supp_May_28_1985.pdf • FOI summary • Official • Jan. 25, 2022
    FDA FOI summary for application 120648
  • N121473_Suppl_5_31_1994.pdf • FOI summary • Official • May 6, 2021
    FDA FOI summary for application 121473
  • ucm069818.pdf • FOI summary • Official • May 6, 2021
    FDA FOI summary for application 121473
  • UCM471258.pdf • FOI summary • Official • April 12, 2021
    FDA FOI summary for application 141449
  • UCM488824.pdf • FOI summary • Official • April 12, 2021
    FDA FOI summary for application 141449
  • FOI Summary sN 141-449 Approved January 5, 2018.pdf • FOI summary • Official • April 12, 2021
    FDA FOI summary for application 141449

Data Sources & Change Log

Every non-trivial field is expected to include provenance and update timestamps.

Official 155 Clinical 1 Manufacturer 0 Marketing 0
Current Field Facts
  • side_effects: Top reported reactions (openFDA): Lack of efficacy (endoparasite) - hookworm, Vomiting, INEFFECTIVE, HOOKS, Diarrhoea, Other abnormal test result NOS, Lack of … (Clinical, 2026-04-11)
  • contraindications: Sprinkle the appropriate amount of drug on a small amount of the usual grain ration. Prepare for each horse individually. Withholding feed or water is not nece… (Official, 2026-04-12)
  • contraindications: Sprinkle the appropriate amount of drug on a small amount of the usual grain ration. Prepare for each horse individually. Withholding feed or water is not nece… (Official, 2026-04-11)
  • contraindications: Sprinkle the appropriate amount of drug on a small amount of the usual grain ration. Prepare for each horse individually. Withholding feed or water is not nece… (Official, 2026-02-12)
  • indications: For the treatment and control of adult Ascaridia galli in broiler chickens and replacement chickens intended to become breeding chickens and for the treatment … (Official, 2026-08-06)
  • indications: For the treatment and control of adult Ascaridia galli in broiler chickens and replacement chickens intended to become breeding chickens and for the treatment … (Official, 2026-08-05)
  • indications: For the treatment and control of adult Ascaridia galli in broiler chickens and replacement chickens intended to become breeding chickens and for the treatment … (Official, 2026-08-04)
  • indications: For the treatment and control of adult Ascaridia galli in broiler chickens and replacement chickens intended to become breeding chickens and for the treatment … (Official, 2026-08-03)
  • indications: For the treatment and control of adult Ascaridia galli in broiler chickens and replacement chickens intended to become breeding chickens and for the treatment … (Official, 2026-08-02)
  • indications: For the treatment and control of adult Ascaridia galli in broiler chickens and replacement chickens intended to become breeding chickens and for the treatment … (Official, 2026-08-01)
  • indications: For the treatment and control of adult Ascaridia galli in broiler chickens and replacement chickens intended to become breeding chickens and for the treatment … (Official, 2026-07-31)
  • indications: For the treatment and control of adult Ascaridia galli in broiler chickens and replacement chickens intended to become breeding chickens and for the treatment … (Official, 2026-07-30)
  • indications: For the treatment and control of adult Ascaridia galli in broiler chickens and replacement chickens intended to become breeding chickens and for the treatment … (Official, 2026-07-29)
  • indications: For the treatment and control of adult Ascaridia galli in broiler chickens and replacement chickens intended to become breeding chickens and for the treatment … (Official, 2026-07-28)
  • indications: For the treatment and control of adult Ascaridia galli in broiler chickens and replacement chickens intended to become breeding chickens and for the treatment … (Official, 2026-07-27)
  • indications: For the treatment and control of adult Ascaridia galli in broiler chickens and replacement chickens intended to become breeding chickens and for the treatment … (Official, 2026-07-26)
  • indications: For the treatment and control of adult Ascaridia galli in broiler chickens and replacement chickens intended to become breeding chickens and for the treatment … (Official, 2026-07-25)
  • indications: For the treatment and control of adult Ascaridia galli in broiler chickens and replacement chickens intended to become breeding chickens and for the treatment … (Official, 2026-07-25)
  • indications: For the treatment and control of adult Ascaridia galli in broiler chickens and replacement chickens intended to become breeding chickens and for the treatment … (Official, 2026-07-22)
  • indications: For the treatment and control of adult Ascaridia galli in broiler chickens and replacement chickens intended to become breeding chickens and for the treatment … (Official, 2026-07-22)
Recent Revisions
  • side_effects updated 2026-04-12 10:05 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-04-12 10:05 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-04-12 10:05 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-04-11 10:05 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-04-11 10:05 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-04-11 10:05 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields

FDA Products & Applications (Animal Drugs @ FDA)

Official sponsor/proprietary-name/application-status records linked by active ingredient.

Product Sponsor Application Status Published
Safe-Guard® Safe-Guard® EnProAl®
OTC
Fenbendazole
Medicated Feed Block Oral
Intervet, Inc. NADA 139-189 Approved Apr 28, 2026
Safe-Guard®
OTC
Fenbendazole
Type A Medicated Article Oral
Intervet, Inc. NADA 131-675 Approved Apr 10, 2026
Defendazole™
OTC
Fenbendazole
Oral Suspension Oral
Norbrook Laboratories, Ltd. ANADA 200-831 Approved Feb 2, 2026
Safe-Guard®
OTC
Fenbendazole
Paste Oral
Intervet, Inc. NADA 132-872 Approved Oct 12, 2023
Safe-Guard® Panacur®
OTC
Fenbendazole
Liquid (Suspension) Oral
Intervet, Inc. NADA 128-620 Approved Jun 6, 2022
safe-guard® panacur®
OTC
Fenbendazole
Paste Oral
Intervet, Inc. NADA 120-648 Approved Jan 25, 2022
Panacur® C (OTC) Safe-Guard® Canine (OTC) Panacur® Granules 22.2% (Rx)
OTC
Fenbendazole
Top Dressing In Feed Oral
Intervet, Inc. NADA 121-473 Approved May 6, 2021
Safe-Guard® AquaSol
OTC
Fenbendazole
Oral Suspension Oral
Intervet, Inc. NADA 141-449 Approved Apr 12, 2021

Data source: FDA Animal Drugs @ FDA (public search export).

What It's For (FDA Label Highlights)

Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.

Species: Beef
Composition / specifications
Each pound of molasses block contains 750 milligrams of fenbendazole. Each pound of protein block contains 750 milligrams of fenbendazole.
Cattle (beef)
Indication

For the treatment and control of: Lungworms: Adult Dictyocaulus viviparus; Stomach worms: Adult brown stomach worms (Ostertagia ostertagi), Adult and fourth stage larvae barberpole worms (Haemonchus contortus), fourth stage larvae barberpole worms (H. placei), and Adult and fourth stage larvae small stomach worms (Trichostrongylus axei); Intestinal worms (Adult and fourth stage larvae): hookworms (Bunostomum phlebotomum), thread-necked intestinal worms (Nematodirus helvetianus), small intestinal worms (Cooperia punctata & C. oncophora), bankrupt worms (Trichostrongylus colubriformis), and nodular worms (Oesophagostomum radiatum).

Dosage

Feed free-choice at a rate of 0.1 pound of block per 100 lb body weight (BW) per day for 3 days to deliver a total of 2.27 mg fenbendazole/lb BW (5 mg/kg BW). Do not underdose. Ensure each animal receives a complete dose based on a current body weight. Underdosing may result in ineffective treatment, and encourage the development of parasite resistance. Consult a veterinarian for assistance in the diagnosis, treatment, and control of parasitism.

Limitations

Administer free choice of beef cattle on pasture that have become accustomed to non-medicated block feeding during an adaptation period of 12 to 19 days. Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism.

FDA page: Open in Animal Drugs @ FDA

Species: Gilts • Growing • Pregnant sows • Boars • Beef And Dairy • Zoo Animals • Swine • Wild Animals
Composition / specifications
Type A medicated articles conatianing 4 percent (18.1 grams per pound), 8 percent (36.2 grams per pound), and 20 percent (90.7 grams per pound) fenbendazole.
Bighorn sheep
Indication

For the treatment and control of: Lungworms (Protostrongylus spp.).

Dosage

10 mg fenbendazole/kg body weight/day x 3 days of treatment

Limitations
Feral Swine
Indication

For the treatment and control of: kidney worms (Stephanurus dentatus), roundworms (Ascaris suum), and nodular worms (Oesophagostomum dentatum).

Dosage

3 mg fenbendazole/kg body weight/day x 3 days of treatment

Limitations
Wildlife and Zoo Ruminants (Subfamily Antilopinae, Hippotraginae, and Caprinae)
Indication

For the treatment and control of: Stomach worms: small stomach worms (Trichostrongylus spp.), barberpole worms (Haemonchus spp.); Intestinal worms: thread-necked intestinal worms (Nematodirus spp.) and whipworms (Trichuris spp.)

Dosage

2.5 mg fenbendazole/kg body weight/day x 3 days of treatment

Limitations
Growing Turkeys
Indication

For the treatment and control of: Gastrointestinal worms: Roundworms, Adults and larvae (Ascaridia dissimilis); Cecal worms, Adults and larvae (Heterakis gallinarum), an important vector of Histomonas meleagridis (Blackhead).

Dosage

14.5 g fenbendazole/ton of feed, to be fed as the sole ration for 6 days

Limitations
Swine (Growing pigs, gilts, pregnant sows, and boars)
Indication

For the treatment and control of: Lungworms: Adult Metastrongylus apri, adult Metastrongylus pudendotectus; Gastrointestinal worms: Adult and larvae (L3, L4 stages, liver, lung, intestinal forms) large roundworms (Ascaris suum), Adult nodular worms (Oesophagostomum dentatum, O. quadrispinulatum), Adult small stomach worms (Hyostrongylus rubidus), Adult and larvae (L2, L3, L4 stages- intestinal mucosal forms) whipworms (Trichuris suis); and Kidney worms: Adult and larvae Stephanurus dentatus.

Dosage

9 mg fenbendazole per kg body weight (4.08 mg fenbendazole per pound) to be fed as the sole ration over a period of 3 to 12 days.

Limitations
Cattle (Dairy and Beef Cattle)
Indication

For the treatment and control of: Lungworms: Adult Dictyocaulus viviparus; Stomach worms: Adult brown stomach worms (Ostertagia ostertagi), Adult and fourth stage larvae barberpole worms (Haemonchus contortus), fourth stage larvae barberpole worms (H. placei), and Adult and fourth stage larvae small stomach worms (Trichostrongylus axei); Intestinal worms (Adult and fourth stage larvae): hookworms (Bunostomum phlebotomum), thread-necked intestinal worms (Nematodirus helvetianus), small intestinal worms (Cooperia punctata & C. oncophora), bankrupt worms (Trichostrongylus colubriformis), and nodular worms (Oesophagostomum radiatum)

Dosage

5 mg fenbendazole per kg body weight in a one (1) day treatment (2.27 mg fenbendazole per pound). Feed as the sole ration for one (1) day. Free-Choice Feeds: Type C free-choice medicated feed must be manufactured by a licensed feed mill according to an approved formula to provide a total of 5 mg per kg body weight fenbendazole over 3 to 6 days.

Limitations
Horses
Indication

For the treatment and control of: Large strongyles (Strongylus edentatus, S. equinus, S. vulgaris, Triodontophorus spp.), Small strongyles (Cyathostomum spp., Cylicocyclus spp., Cylicostephanus spp.), Pinworms (Oxyuris equi), and Ascarids (Parascaris equorum).

Dosage

For the control of large strongyles, small strongyles, and pinworms the recommended dose is 5 mg fenbendazole per kg body weight (2.27 mg fenbendazole per pound) in a one (1) day treatment. For the control of ascarids the recommended dose is 10 mg fenbendazole per kg body weight (4.54 mg fenbendazole per pound) in a one (1) day treatment.

Limitations
Wild quail
Indication

For the treatment and control of Gastrointestinal worms: Cecal worms, (Aulonocephalus spp.).

Dosage

90.7 g of fenbendazole/ton of Type C medicated feed, to be fed for 21 consecutive days.

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Beef And Dairy
Composition / specifications
100 mg/mL (10%)
Beef and Dairy Cattle
Indication

For the treatment and control of:
Lungworms: Adult Dictyocaulus viviparus;
Stomach worms: Adult brown stomach worms (Ostertagia ostertagi), Adult and fourth stage larvae barberpole worms (Haemonchus contortus & H. placei), and Adult and fourth stage larvae small stomach worms (Trichostrongylus axei);
Intestinal worms (Adult and fourth stage larvae): hookworms (Bunostomum phlebotomum), thread-necked intestinal worms (Nematodirus helvetianus), small intestinal worms (Cooperia punctata & C. oncophora), bankrupt worms (Trichostrongylus colubriformis), and nodular worms (Oesophagostomum radiatum).

Dosage

2.3 mg/lb (5 mg/kg) body weight

Limitations
Goats
Indication

For the treatment and control of:
Stomach worms (adults): Haemonchus contortus and Teladorsagia circumcincta.

Dosage

2.3 mg/lb (5 mg/kg) body weight

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Beef • Dairy
Composition / specifications
The product is an aqueous paste containing 10 percent fenbendazole.
Beef and dairy cattle
Indication

For the treatment and control of: Lungworms: Adult Dictyocaulus viviparus; Stomach worms: Adult brown stomach worms (Ostertagia ostertagi), Adult and fourth stage larvae barberpole worms (Haemonchus contortus), fourth stage larvae barberpole worms (H. placei), and Adult and fourth stage larvae small stomach worms (Trichostrongylus axei); Intestinal worms (Adult and fourth stage larvae): hookworms (Bunostomum phlebotomum), thread-necked intestinal worms (Nematodirus helvetianus), small intestinal worms (Cooperia punctata & C. oncophora), bankrupt worms (Trichostrongylus colubriformis), and nodular worms (Oesophagostomum radiatum).

Dosage
Administer orally 5 milligrams per kilogram of body weight (2.3 milligrams per pound).
Limitations

Do not underdose. Ensure each animal receives a complete dose based on a current body weight. Underdosing may result in ineffective treatment, and encourage the development of parasite resistance. Consult a veterinarian for assistance in the diagnosis, treatment, and control of parasitism.

FDA page: Open in Animal Drugs @ FDA

Species: Non-Lactating • Beef • Dairy
Composition / specifications
The drug is a suspension containing 10 percent (100 milligrams per milliliter) fenbendazole.
Cattle (beef and dairy)
Indication

For the treatment and control of: Lungworms: Adult Dictyocaulus viviparus; Stomach worms: Adult brown stomach worms (Ostertagia ostertagi), Adult and fourth stage larvae barberpole worms (Haemonchus contortus & H. placei), and Adult and fourth stage larvae small stomach worms (Trichostrongylus axei); Intestinal worms (Adult and fourth stage larvae): hookworms (Bunostomum phlebotomum), thread-necked intestinal worms (Nematodirus helvetianus), small intestinal worms (Cooperia punctata & C. oncophora), bankrupt worms (Trichostrongylus colubriformis), and nodular worms (Oesophagostomum radiatum).

Dosage

Administer orally at a dose of 2.3 mg/lb (5 mg/kg) body weight.

Limitations
Goats
Indication

For the treatment and control of: Stomach worms (adults): Haemonchus contortus and Teladorsagia circumcincta.

Dosage

Administer orally at a dose of 2.3 mg/lb (5 mg/kg) body weight.

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Horse • Pony
Composition / specifications
The product is an aqueous paste containing 10 percent fenbendazole.
Horses
Indication

For the treatment and control of large strongyles (Strongylus edentatus, S. equinus, S. vulgaris), encysted early 3rd stage (hypobiotic), late 3rd stage and 4th stage cyathostome larvae, small strongyles, pinworms (Oxyuris equi), ascarids (Parascaris equorum), and for the control of arteritis caused by 4th stage larvae of Strongylus vulgaris in horses.

Dosage

For large strongyles, small strongyles, and pinworms, the recommended dose is 5 mg/kg (2.3 mb/lb) administered once orally. For ascarids, the recommended dose is 10 mg/kg (4.6 mg/lb) administered once orally. For treatment and control of hypobiotic (encysted early 3rd stage), late 3rd stage, and 4th stage cyathostome larvae, as well as 4th stage Strongylus vulgaris larvae, the recommended dose is 10 mg/kg (4.6 mg/lb) administered orally daily for 5 consecutive days.

Limitations

Do not use in horses intended for human consumption. Consult your veterinarian for assistance in the diagnosis, treatment and control of parasitism.

FDA page: Open in Animal Drugs @ FDA

Species: Dog
Composition / specifications
The drug is in granular form containing 22 percent (222 milligrams per gram) fenbendazole.
Dogs
Indication
For the treatment and control of ascarids (Toxocara canis, Toxascaris leonina), hookworms (Ancylostoma caninum, Uncinaria stenocephala), whipworms (Trichuris vulpis), and tapeworms (Taenia pisiformis).
Dosage
50 milligrams per kilogram (22.7 milligrams per pound) daily for 3 consecutive days.
Limitations

Mix the appropriate amount of drug with a small amount of the usual food. Dry dog food may require slight moistening to facilitate mixing. Medicated food must be fully consumed. 

FDA page: Open in Animal Drugs @ FDA

Species: Swine • Breeders • Broilers • Layers • Replacements
Composition / specifications
200 mg/mL
Swine (Except Nursing Piglets)
Indication

For the treatment and control of: Lungworms: Adult Metastrongylus apri, adult Metastrongylus pudendotectus; Gastrointestinal worms: Adult and larvae (L3, L4 stages, liver, lung, intestinal forms) large roundworms (Ascaris suum), Adult nodular worms (Oesophagostomum dentatum, O. quadrispinulatum), Adult small stomach worms (Hyostrongylus rubidus), Adult and larvae (L2, L3, L4 stages- intestinal mucosal forms) whipworms (Trichuris suis); and Kidney worms: Adult and larvae Stephanurus dentatus.

Dosage
2.2 mg fenbendazole/kg body weight (BW) (1 mg/lb) daily for 3 consecutive days
Limitations
Chickens (broilers, replacements, breeding, and laying hens)
Indication

For the treatment and control of adult Ascaridia galli in broiler chickens and replacement chickens and for the treatment and control of adult A. galli and Heterakis gallinarum in breeding chickens and laying hens.

Dosage
1 mg/kg BW (0.454 mg/lb)/day for 5 consecutive days
Limitations

FDA page: Open in Animal Drugs @ FDA

Usage

For the treatment and control of large strongyles ( Strongylus edentatus , S. equinus , S. vulgaris , Triodontophorus spp.),small strongyles ( Cyathostomum spp., Cylicocyclus spp., Cylicostephanus spp., Cylicodontophorus spp.), and pinworms ( Oxyuris equi ). For the treatment and control of ascarids ( Parascaris equorum ). For the control of infections of large strongyles (Strongylus edentatus, S. equinus, S. vulgaris), small strongyles, pinworms (Oxyuris equi), and ascarids (Parascaris equorum).

Source: FDA Animal Drugs @ FDA • Reference

Contraindications

Sprinkle the appropriate amount of drug on a small amount of the usual grain ration. Prepare for each horse individually. Withholding feed or water is not necessary. Retreat in 6 to 8 weeks if required. Do not use in horses intended for food. Consult your veterinarian assistance in the diagnosis, treatment, and control of parasitism. Do not use in horses intended for human consumption. Consult your veterinarian for assistance in the diagnosis, treatment and control of parasitism. Mix the appropriate amount of drug with a small amount of the usual food. Dry dog food may require slight moistening to facilitate mixing. Medicated food must be fully consumed.

Top Reported Reactions (openFDA)

De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).

Digestive
Diarrhea (1) • Dog Bloody diarrhoea (1) • Dog

Showing top 5 for Digestive.

Skin & allergy
Hair loss (1) • Dog

Showing top 5 for Skin & allergy.

Neurologic
Unsteady walking (1) • Dog Depression (1) • Cat

Showing top 5 for Neurologic.

Behavior
Behavioral disorder (1) • Cat

Showing top 5 for Behavior.

Other
Distension of abdomen (1) • Dog Disorder of gastrointestinal flora (1) • Cat Digestive tract neoplasm NOS (1) • Cat Decreased red blood cell count (1) • Dog Decreased percentage of reticulocytes (1) • Dog
Show more (21)
Decreased packed cell volume (1) • Cat Decreased haemoglobin (1) • Dog Decreased haematocrit (1) • Dog Decreased body temperature (1) • Cat Decreased blood urea nitrogen (BUN) or creatinine (1) • Cat Decreased activity (1) • Cat Death by euthanasia (1) • Dog Death (1) • Cat Cough (1) • Dog Corneal opacity (1) • Dog Cloudy eye (1) • Dog Bloody stool (1) • Dog Blood in urine (1) • Dog Bloated (1) • Cat Bacterial skin infection NOS (1) • Dog Anal and rectal disorder NOS (1) • Dog Anaemia NOS (1) • Cat Allergy NOS (1) • Dog Abnormal radiograph finding (1) • Cat Abnormal cytology (1) • Cat Abnormal breathing (1) • Dog

Showing top 5 for Other.

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Adverse Event Case Summaries (openFDA)

These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.

Dog, ['Beagle', 'Dog (unknown)'], Male, 1 year, 14.15 kilogram • Drug: MSK, Unknown • Reactions: Lack of efficacy (endoparasite) - hookworm • Outcome: Outcome Unknown

  • Report ID: USA-USFDACVM-2026-US-014244
  • Serious AE: No
  • Treated For AE: Yes
  • Sex: Male
  • Age: 1.00 Year
  • Weight: 14.150 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
Reactions Reported:
Lack of efficacy (endoparasite) - hookworm
Outcomes: Outcome Unknown

Dog, ['Retriever - Golden', 'Poodle (unspecified)'], Male, 5 year, 27.699 kilogram • Drug: MSK, Unknown • Reactions: Lack of efficacy (endoparasite) - hookworm, Licking, Localised pain NOS, Pododermatitis, Allergy NOS • Outcome: Outcome Unknown

  • Report ID: USA-USFDACVM-2026-US-014241
  • Serious AE: No
  • Treated For AE: Yes
  • Sex: Male
  • Age: 5.00 Year
  • Weight: 27.699 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
Reactions Reported:
Lack of efficacy (endoparasite) - hookworm Licking Localised pain NOS Pododermatitis Allergy NOS
Outcomes: Outcome Unknown

Cat, Domestic Shorthair, Male, 11 week, 1.4 kilogram • Drug: MSK, Unknown • Reactions: Soft stool, Bloated, Disorder of gastrointestinal flora, Vomiting, Depression… • Outcome: Recovered/Normal

  • Report ID: USA-USFDACVM-2026-US-014167
  • Serious AE: No
  • Treated For AE: Yes
  • Sex: Male
  • Age: 11.00 Week
  • Weight: 1.400 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
Reactions Reported:
Soft stool Bloated Disorder of gastrointestinal flora Vomiting Depression Increased heart rate Bloody stool Bloody diarrhoea
Outcomes: Recovered/Normal

Dog, Retriever - Labrador, Female, 5 year, 36.73 kilogram • Drug: MSK, Oral • Reactions: Lack of efficacy (endoparasite) - hookworm • Outcome: Outcome Unknown

  • Report ID: USA-USFDACVM-2026-US-012371
  • Serious AE: No
  • Treated For AE: No
  • Sex: Female
  • Age: 5.00 Year
  • Weight: 36.730 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Oral
Reactions Reported:
Lack of efficacy (endoparasite) - hookworm
Outcomes: Outcome Unknown

Dog, ['Siberian Husky', 'Shepherd Dog - German'], Male, 9 year, 41.277 kilogram • Drug: MSK, Unknown • Reactions: Other abnormal test result NOS, Lack of efficacy (endoparasite) - heartworm, Tiredness (lethargy), Death by euthanasia, Blood in urine… • Outcome: Euthanized

  • Report ID: USA-USFDACVM-2026-US-014359
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 9.00 Year
  • Weight: 41.277 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
Reactions Reported:
Other abnormal test result NOS Lack of efficacy (endoparasite) - heartworm Tiredness (lethargy) Death by euthanasia Blood in urine Cloudy eye Cough Swelling NOS Corneal opacity Urine abnormalities NOS Weakness Increased lung sounds Haemolytic anaemia Not eating Abnormal breathing Walking difficulty Decreased red blood cell count Decreased percentage of reticulocytes
Outcomes: Euthanized

Dog, ['Beagle', 'Dog (unknown)'], Female, 8 year, 22.044 kilogram • Drug: MSK, Unknown • Reactions: Lack of efficacy (endoparasite) - roundworm NOS, Lack of efficacy (endoparasite) - hookworm, Excessive appetite, Anal and rectal disorder NOS • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2026-US-013526
  • Serious AE: No
  • Treated For AE: Yes
  • Sex: Female
  • Age: 8.00 Year
  • Weight: 22.044 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
Reactions Reported:
Lack of efficacy (endoparasite) - roundworm NOS Lack of efficacy (endoparasite) - hookworm Excessive appetite Anal and rectal disorder NOS
Outcomes: Ongoing

Dog, Crossbred Canine/dog, Male, 9 week • Drug: MSK, Unknown • Reactions: Death by euthanasia, Lack of efficacy (bacteria) - Bordetella, Skin lump, Decreased haemoglobin, Hypokalaemia… • Outcome: Euthanized

  • Report ID: USA-USFDACVM-2026-US-008597
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 9.00 Week
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
Reactions Reported:
Death by euthanasia Lack of efficacy (bacteria) - Bordetella Skin lump Decreased haemoglobin Hypokalaemia Decreased haematocrit Other abnormal test result NOS Low amylase Hyperproteinaemia Decreased packed cell volume Reduced globulins Eosinopenia Hyperphosphataemia Low platelet count Elevated creatine-kinase Hypoproteinaemia Elevated creatinine Elevated triglyceride Hyperglycaemia Neutrophilia Decreased percentage of reticulocytes Increased band neutrophilia Monocytosis Elevated serum alkaline phosphatase Leukocytosis NOS Elevated symmetrical dimethylarginine Hypoalbuminaemia Elevated aspartate aminotransferase Elevated total bilirubin Decreased red blood cell count Neutropenia Lymphopenia Hypernatraemia Elevated C-reactive protein Elevated alanine aminotransferase Elevated cholesterol Hyperchloraemia Elevated blood urea nitrogen Hypochloraemia Elevated lipase Distension of abdomen Leukopenia NOS
Outcomes: Euthanized

Cat, Domestic Shorthair, Male, 7 month, 2.72 kilogram • Drug: MSK, Unknown • Reactions: Hair loss NOS • Outcome: Outcome Unknown

  • Report ID: USA-USFDACVM-2026-US-007114
  • Serious AE: No
  • Treated For AE: No
  • Sex: Male
  • Age: 7.00 Month
  • Weight: 2.720 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
Reactions Reported:
Hair loss NOS
Outcomes: Outcome Unknown

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Overdose Information

No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.

Storage & Handling

No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.

Share Your Thoughts

Let others know your experience or advice regarding this medication.

This medication has not been reviewed by a veterinarian yet.